Increased Folate Intake with No Changes in Serum Homocysteine and Decreased Levels of C-Reactive Protein in Patients with Inflammatory Bowel Diseases

被引:18
|
作者
Chiarello, P. G. [1 ]
Penaforte, F. R. O. [1 ]
Japur, C. C. [1 ]
Souza, C. D. A. S. [1 ]
Vannucchi, H. [1 ]
Troncon, L. E. A. [1 ]
机构
[1] USP, Fac Med, Dept Internal Med, BR-14049190 Ribeirao Preto, SP, Brazil
关键词
Inflammatory bowel disease; Homocysteine; Folic acid; C-reactive protein; ULCERATIVE-COLITIS; CROHNS-DISEASE; METHYLENETETRAHYDROFOLATE REDUCTASE; THROMBOEMBOLIC COMPLICATIONS; FOLIC-ACID; PREVALENCE; HYPERHOMOCYSTEINEMIA; MARKERS; WOMEN; RISK;
D O I
10.1007/s10620-008-0398-4
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
In order to increase dietary folic acid intake and to improve nutritional status regarding folate by controlling homocysteine concentrations, ten patients with inflammatory bowel diseases (Crohn's disease in the colon and ulcerative colitis) received individualized nutritional guidance and were followed up as outpatients for 2 months. The following procedures were performed at the beginning of the study (T0), after 1 month (T1) and at the end of the study (T2): collection of anthropometric data (weight and height), dietary data (24 h diet recall), and blood under fasting condition for the determination of serum folic acid, homocysteine, C-reactive protein, and vitamin B12. Plasma folic acid deficiency was not detected but hyperhomocysteinemia was present in six individuals and C-reactive protein (CRP) was increased (> 0.5 mg/dl) in seven patients. After the patients were instructed there was a significant increase in vitamin B6 intake (about 35%) and in folate intake (49.6%). Mean plasma levels of folic acid, homocysteine, and vitamin B12 did not change, but there was a significant decrease of CRP at T1, 0.36 mg dl(-1) on average (P = 0.01), which was maintained at T2. We conclude that the increased folate intake reported by this group of patients was not reflected in improved serum concentrations of folic acid and homocysteine. However, the guidelines for the patients probably induced them to choose a more adequate diet, providing nutrients that help control the inflammatory process.
引用
收藏
页码:627 / 633
页数:7
相关论文
共 50 条
  • [1] Increased Folate Intake with No Changes in Serum Homocysteine and Decreased Levels of C-Reactive Protein in Patients with Inflammatory Bowel Diseases
    P. G. Chiarello
    F. R. O. Penaforte
    C. C. Japur
    C. D. A. S. Souza
    H. Vannucchi
    L. E. A. Troncon
    Digestive Diseases and Sciences, 2009, 54 : 627 - 633
  • [2] Serum Amyloid A as a Potential Biomarker in Inflammatory Bowel Diseases, Especially in Patients with Low C-Reactive Protein
    Stute, Marie
    Kreysing, Martin
    Zorn, Markus
    Michl, Patrick
    Gauss, Annika
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (02)
  • [3] Association between Corrected QT Interval and C-Reactive Protein in Patients with Inflammatory Bowel Diseases
    Viscido, Angelo
    Capannolo, Annalisa
    Petroni, Renata
    Stefanelli, Gianpiero
    Zerboni, Giulia
    De Martinis, Massimo
    Necozione, Stefano
    Penco, Maria
    Frieri, Giuseppe
    Latella, Giovanni
    Romano, Silvio
    MEDICINA-LITHUANIA, 2020, 56 (08): : 1 - 15
  • [4] Evaluation of serum levels of homocysteine and C-reactive protein in patients with ischemic stroke
    Yang, Liu
    Xu, Bing
    CELLULAR AND MOLECULAR BIOLOGY, 2022, 68 (07) : 56 - 62
  • [5] Homocysteine and C-reactive protein levels in haemodialysis patients
    Koulouridis E.
    Tzilianos M.
    Katsarou A.
    Costimba I.
    Klonou E.
    Panagiotaki E.
    Georgalidis C.
    Krokida A.
    Delaportas N.
    Lachanas A.
    Karaliotas G.
    Kaliolia I.
    International Urology and Nephrology, 2001, 33 (2) : 207 - 215
  • [6] C-reactive protein as a diagnostic and prognostic factor in inflammatory bowel diseases
    Mankowska-Wierzbicka, Dorota
    Karczewski, Jacek
    Poniedzialek, Barbara
    Grzymislawska, Malgorzata
    Staszewski, Rafal
    Krolczyk, Aleksandra
    Dobrowolska, Agnieszka
    Grzymislawski, Marian
    POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2016, 70 : 1124 - 1130
  • [7] Relationship between the tumor necrosis factor alpha polymorphism and the serum C-reactive protein levels in inflammatory bowel disease
    Vatay, A
    Bene, L
    Kovács, A
    Prohászka, Z
    Szalai, C
    Romics, L
    Fekete, B
    Karádi, I
    Füst, G
    IMMUNOGENETICS, 2003, 55 (04) : 247 - 252
  • [8] Relationship between the tumor necrosis factor alpha polymorphism and the serum C-reactive protein levels in inflammatory bowel disease
    Ágnes Vatay
    László Bene
    Ágota Kovács
    Zoltán Prohászka
    Csaba Szalai
    László Romics
    Béla Fekete
    István Karádi
    George Füst
    Immunogenetics, 2003, 55 : 247 - 252
  • [9] Evaluation of the Relationship between Serum Ghrelin, C-Reactive Protein and Interleukin-6 Levels, and Disease Activity in Inflammatory Bowel Diseases
    Cekic, Cem
    Arabul, Mahmut
    Alper, Emrah
    Pakoz, Zehra Betul Kocal
    Saritas, Elif
    Yuksel
    Unsal, Belkis
    HEPATO-GASTROENTEROLOGY, 2014, 61 (133) : 1196 - 1200
  • [10] Homocysteine and C-reactive protein levels in women with polycystic ovary syndrome
    Gozukucuk, Murat
    Gursoy, Asli Yarci
    Destegul, Emre
    Taskin, Salih
    Satiroglu, Hakan
    GYNECOLOGY AND MINIMALLY INVASIVE THERAPY-GMIT, 2021, 10 (04): : 210 - 214